Similar articles

• [New anthracycline analogues in the treatment of lung cancer].

  Ueoka H, Ohnoshi T, Kimura I. Ueoka H, et al. Gan To Kagaku Ryoho. 1992 Nov;19(13):2146-9. Gan To Kagaku Ryoho. 1992. PMID: 1332624 Review. Japanese.
• [Profile of the anti-tumor effects of amrubicin, a completely synthetic anthracycline].

  Hanada M, Noguchi T, Murayama T. Hanada M, et al. Nihon Yakurigaku Zasshi. 2003 Aug;122(2):141-50. doi: 10.1254/fpj.122.141. Nihon Yakurigaku Zasshi. 2003. PMID: 12890900 Japanese.
• Amrubicin for the treatment of advanced lung cancer.

  Kurata T. Kurata T. Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):171-80. doi: 10.1517/17425250802670508. Expert Opin Drug Metab Toxicol. 2009. PMID: 19239396 Review.
• Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.

  Kramer BS, Birch R, Gockerman JP, Greco A, Prestridge K. Kramer BS, et al. Cancer Treat Rep. 1986 Jun;70(6):803-4. Cancer Treat Rep. 1986. PMID: 3015404 Clinical Trial. No abstract available.
• [Chemotherapy for lung cancer].

  Kurata T, Fukuoka M. Kurata T, et al. Nihon Rinsho. 2002 May;60 Suppl 5:309-16. Nihon Rinsho. 2002. PMID: 12101679 Review. Japanese. No abstract available.